Hematology Diagnostics Market Size 2023 to 2032 Status and Trend by Companies, Regional Outlook

Comments · 416 Views

The global hematology diagnostics market is anticipated to grow at a moderate CAGR of 5.8% from 2023 to 2032. The market's revenue surged to $6.1 billion in 2022, and it is expected to further accelerate, reaching a notable $10.7 billion by 2032.

According to a new report published by KD Market Insights, titled, “Hematology Diagnostics Market Insights, Trends, Opportunity Forecast, 2023–2032,” the global hematology diagnostics market size is anticipated to witness moderate growth during the forecast period i.e., 2023-2032. The Increasing occurrence of blood disorders, there is a growing demand for medicine and precision diagnostics, Advancements in technology, Expansion of healthcare infrastructure in developing regions and Introduction of point of care testing and home based testing which are the major factors augmenting the growth of the global hematology diagnostics market. The global hematology diagnostics market is anticipated to grow at a moderate CAGR of 5.8% from 2023 to 2032. The market's revenue surged to $6.1 billion in 2022, and it is expected to further accelerate, reaching a notable $10.7 billion by 2032.

The increasing occurrence of blood disorders, like anemia, leukemia and lymphoma among others is driving the need for tools and equipment. Furthermore, advancements in technology have led to the creation of tools such as flow cytometers and molecular diagnostics, are further expected to create ample growth opportunities for the global hematology diagnostics market during the forecast period i.e., 2023-2032. Moreover, the growing demand for medicine and precision diagnostics, has propelled market expansion. Introduction of point of care testing and home based testing, is expected to contribute towards the market growth during the period.

The North America region accounted for the largest share in the global hematology diagnostics market in 2022. The region is further projected to continue dominating in the market during the forecast period. This can be attributed to the high prevalence of blood disorders and the presence of well-established healthcare infrastructure.

According to product, the hematology analyzers segment accounted for the largest market share in the hematology diagnostics market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.

Download Exclusive Sample Report@ https://www.kdmarketinsights.com/sample/7457

The global hematology diagnostics market is segmented into product, end-use, test type and region. Based on product, the market is bifurcated into instrument, consumables. Based on end-use, it is classified into hospitals, diagnostic labs, others. Based on test type, it is classified into blood count, platelet function, hemoglobin, hematocrit.

The global hematology diagnostics market is analyzed across North America (U.S. Canada), Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Indonesia, Thailand, Australia, New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America) and Middle East Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, and Rest of Middle East Africa).

Key Insights of Hematology Diagnostics Market

  • On the basis of product type, the hematology analyzers segment accounted for the largest market share in the hematology diagnostics market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.
  • On the basis of region, North America accounted for the largest share in the global hematology diagnostics market in 2022. The region is further projected to continue dominating in the market during the forecast period.
  • On the basis of region, Europe is estimated to account for the second largest share in the market during the forecast period.

Some of the major hematology diagnostics companies profiled in the report include Beckman Coulter, Inc., Siemens Healthineers, Mindray Medical International Limited, F. Hoffmann-La Roche Ltd., Sysmex Corporation, Abbott Laboratories, Bio-Rad Laboratories, Thermo Fisher Scientific, Danaher Corporation, Instrumentation Laboratory, DiaSorin S.p.A., Ortho Clinical Diagnostics, PerkinElmer Inc.

Browse Full Report Along With Facts and Figures@ https://www.kdmarketinsights.com/reports/hematology-diagnostics-market/7457

Browse Trending Reports:

https://www.kdmarketinsights.com/reports/protein-characterization-and-identification-market/7301

https://www.kdmarketinsights.com/reports/continuous-renal-replacement-therapy-market/7291

https://www.kdmarketinsights.com/reports/obstructive-hypertrophic-cardiomyopathy-market/7285

https://www.kdmarketinsights.com/reports/electron-beam-linear-accelerator-market/7279

https://www.kdmarketinsights.com/reports/chronic-kidney-disease-drugs-market/7278

About KD Market Insights

KD Market Research Company is a reputable and industry-leading market research firm that offers insightful insights, Analytics, and Research Reports for a variety of industries. With an emphasis on providing accurate and actionable market insights and data, our team of experienced research analysts conducts exhaustive research to assist businesses in making informed decisions. Whether you require market forecasts, competitive analysis, or the identification of trends, we offer comprehensive solutions tailored to your specific requirements. Stay ahead of the competition with the dependable market research services of KD Market Research Company.

Contact Us:

KD Market Insights

150 State Street, Albany,

New York, USA 12207

+1 (518) 300-1215

Email: sales@kdmarketinsights.com

Website: www.kdmarketinsights.com

 

Comments